Inogen (INGN) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Inogen (INGN) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 43.57% |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.55% |
| Mar 31, 2026 | 65.07% |
| Dec 31, 2025 | 82.52% |
| Sep 30, 2025 | 68.63% |
| Jun 30, 2025 | 58.88% |
| Mar 31, 2025 | 9.02% |
| Dec 31, 2024 | 84.01% |
| Sep 30, 2024 | -54.37% |
| Jun 30, 2024 | -117.23% |
| Mar 31, 2024 | -86.76% |
| Sep 30, 2023 | -20.25% |
| Jun 30, 2023 | 36.91% |
| Mar 31, 2023 | -48.42% |
| Dec 31, 2022 | 6.49% |
| Sep 30, 2022 | -75.27% |
| Jun 30, 2022 | -40.31% |
| Mar 31, 2022 | -39.28% |
| Dec 31, 2021 | -255.49% |
| Sep 30, 2021 | -68.15% |
| Jun 30, 2021 | -61.17% |